Company Profile
Updated: 30-OCT-09IDIS Ltd.
International Private company
IDIS House, Churchfield Rd., Weybridge, KT13 8DB, United Kingdom
()44 01932 824 200, 44 1932 824 323 fax, http://www.idispharma.com
Primary SIC: Drugs, Proprietaries And Sundries, Primary NAICS: Drugs and Druggists' Sundries Merchant Wholesalers
Description: Wholesale: The sourcing and supply of medicines on a named-patient basis, the supply of drugs for clinical trials and the provision of alternatives when medicines are in short supply.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 12/7/2009; 1188 words; ...has signed a collaborative agreement with Idis, of Weybridge UK, to manage the named...Pa., and MerLion Pharmaceuticals Pte Ltd., of Singapore, said they are evaluating...Switzerland-based F. Hoffmann-La Roche Ltd. is discontinuing developing of RG1507...
EpiCept Corporation Announces Health Canada Accepts Ceplene[R] Application for Review.
Business Wire; 11/9/2009; 1477 words; ...marketing partner for Ceplene([R]) in Israel, Megapharm Ltd., filed the application and will market Ceplene([R]) upon...named patient program for Ceplene([R])in partnership with IDIS under which physicians in all major global markets excluding...
On the move
Pharmaceutical Executive Europe (Online); 7/29/2009; 699 words; ...development director for Therapeutics. He joins from SRA GCD Ltd where he was global VP of Regulatory Affairs & Strategic...internationally in support of our customers' needs," commented IDIS CEO Natalie Douglas. Bertrand Le Bourgeois has been appointed...
EmergingStockReport.com initiates research coverage on: Cell Therapeutics, Inc. (Nasdaq:CTIC).
M2 Presswire; 5/5/2009; 727 words; ...CTIC)(C)1994-2009 M2 COMMUNICATIONS LTD RDATE:05052009 Emerging stock report is...Europe. Pixantrone will be supplied by IDIS to healthcare professionals for the treatment...emergingstockreport.com ((M2 Communications Ltd disclaims all liability for information...
Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer.
M2 Presswire; 4/28/2009; 1789 words; ...Antibodies and Vaccines for Cancer(C)1994-2009 M2 COMMUNICATIONS LTD RDATE:28042009 Dublin - Research and Markets (http://www...Greenovation Biotech - Horizon Discovery - Human Genome Sciences - Idis - ImClone Systems - ImmuneRegen BioSciences - Immunomedics...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning